Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial
收藏Global Health Data Exchange ()2024-06-26 收录
下载链接：
https://ghdx.healthdata.org/record/calcium-antagonist-lacidipine-slows-down-progression-asymptomatic-carotid-atherosclerosis
下载链接
链接失效反馈官方服务：
资源简介：
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial
